Click Icon Below to Download "The Case for Personalized Medicine"
e-Book

Related News & Articles

January 2012

ChinaBio Today - For Saladax Biomedical, China Could Be the Largest Market (Read More)

January 2012

Drug Discovery & Development - Therapy Dose Management During Clinical Development of Oncology Products (Read Full Article)

November 2011

Medical Device DailySaladax's MyCare assays allow for stronger dose optimization (Read Full Article)

October 2011

MergerMarket - Saladax, a Bethlehem, Pennsylvania-based cancer diagnostic company, could exit in 24 to 36 months after it builds additional value (Read Full Article)

September 2011

Clinica - J&J Dx unit joins BMS/Saladax Alzheimer's collaboration (Read Full Article)

March 2011

IVD Technology - Innovation helping to personalize medicine (Read Full Article)

October 2010

Saladax: Providing Biomedical Opportunities in Pennsylvania (Read Full Article)

September 2010

The FDA and Laboratory - The Brouhaha Continues (Read Full Article)

July 2010

HemOnc today - Maximum tolerated exposure:  A more rational approach to drug dosing (Read Full Article)

October 2009

CAP Today  - Uneasy Alliance -- TDM, Oncology Drugs
Saladax CEO Salvatore Salamone featured in College of American Pathologists
 (Read Full Article)

September 2009

Saladax cited by U.S. Commerce Dept. Secretary Locke during Ben Franklin Technology Partners visit (Read Full Article)

May 2009

Personalized Medicine Coalition Publishes The Case for Personalized Medicine, an Updated Report and Analysis on Advances and Challenges  (Read Full Article)

April 2009

Myriad Genetics Launches OnDose, Its Seventh Molecular Diagnostic Product
OnDose Assists Oncologists in Maximizing Chemotherapy Efficacy and Reducing Toxicity
 (Read Full Article)

October 2008
Myriad Genetics (Nasdaq: MYGN, www.myriad.com) Acquires Novel Therapeutic Drug Management Technology from Saladax Biomedical
(Read Full Article)